Alcon Inc.
ALC
NYSE·Healthcare·Medical - Specialties·Mkt cap $34.4B
$70.50
▼ -2.19%
P/E
54.23
Mkt Cap
$34.4B
52-Wk Range
$61.84–$87.64
52-Week Range
$61.84 - $87.64
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 11.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Market-leading position in premium IOL technology with PanOptix and ReSTOR brands
- Comprehensive product portfolio spanning surgical and vision care segments
- Advanced surgical systems including LenSx laser and NGENUITY 3D visualization
- Strong brand recognition and established relationships with eye care professionals
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Stable outlook
Rising prevalence of cataract and refractive surgeries due to aging demographics
Value
Fairly valued vs Medical Devices peers
Momentum
Strong
+5.5% over 3m
Quality
Strong
Strong fundamentals
Dividend
Modest
0.51% yield
Smart-money signal
Who's buying ALC right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 10, 2026
AUG 10, 2026
Reported EPS of $0.84 vs $0.77 consensus (+9.1% surprise). Revenue of $2.8B vs $2.7B expected (+2.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+9.1%
Revenue trend · last 8Q
—
—
+1%
+4%
+7%
+9%
+7%
+6%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$2.5B
$2.5B
$2.5B
$2.6B
$2.6B
$2.7B
$2.7B
$2.8B
Margins · last 8Q
Gross
—
Operating
—
Profit
0.0%
Wall Street consensus
7 analysts · 71% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
71%
Hold
29%
Sell
0%
Median Price Target
—
Latest: Exane BNP Paribas · Aug 13, 2026
vs Industry
How ALC stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related